Alx Oncology Holdings Inc [ALXO] stock is trading at $16.87, up 4.01%. An important factor to consider is whether the stock is rising or falling in short-term value. The ALXO shares have gain 7.18% over the last week, with a monthly amount glided 50.76%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 08, 2024, when Stifel downgraded its rating to a Hold and also boosted its price target to $14 from $10. Previously, Jefferies upgraded its rating to Buy on December 08, 2023, and elevated its price target to $18. On December 22, 2021, downgrade downgraded it’s rating to Hold and revised its price target to $25 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $106 on September 30, 2021. In a note dated April 06, 2021, UBS initiated an Buy rating.
Alx Oncology Holdings Inc [ALXO] stock has fluctuated between $3.94 and $17.42 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $16.87 at the most recent close of the market. An investor can expect a potential return of 54.12% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -3.15 and Total Capital is -0.82. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.07 points at the first support level, and at 15.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.35, and for the 2nd resistance point, it is at 17.82.
Alx Oncology Holdings Inc [ALXO] reported earnings per share of -$0.93 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.84/share, meaning a difference of -$0.09 and a surprise factor of -10.70%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$1.24 per share as compared to estimates of -$0.87 per share, a difference of -$0.37 representing a surprise of -42.50%.
Ratios To Look Out For
For context, Alx Oncology Holdings Inc’s Current Ratio is 5.24. On the other hand, the Quick Ratio is 5.24, and the Cash Ratio is 0.62.
Transactions by insiders
Recent insider trading involved Pons Jaume, PRESIDENT & CSO, that happened on Apr 16 ’24 when 50000.0 shares were sold. PRESIDENT & CSO, Pons Jaume completed a deal on Apr 04 ’24 to sell 20000.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Lettmann Jason bought 4400.0 shares on Mar 14 ’24.
